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We identiﬁed a homozygous missense mutation in the noncatalytic subunit (RAB3GAP2) of RAB3GAP that results
in abnormal splicing in a family with congenital cataracts, hypogonadism, and mild mental retardation (Martsolf
syndrome). Recently, mutations in the catalytic subunit of RAB3GAP (RAB3GAP1), a key regulator of calcium-
mediated hormone and neurotransmitter exocytosis, were reported in Warburg micro syndrome, a severe neuro-
developmental condition with overlapping clinical features. RAB3GAP is a heterodimeric protein that consists of
a catalytic subunit and a noncatalytic subunit encoded by RAB3GAP1 and RAB3GAP2, respectively. We performed
messenger RNA–expression studies of RAB3GAP1 and RAB3GAP2 orthologues in Danio rerio embryos and dem-
onstrated that, whereas developmental expression of rab3gap1 was generalized (similar to that reported elsewhere
in mice), rab3gap2 expression was restricted to the central nervous system. These ﬁndings are consistent with
RAB3GAP2 having a key role in neurodevelopment and may indicate that Warburg micro and Martsolf syndromes
represent a spectrum of disorders. However, we did not detect RAB3GAP2 mutations in patients with Warburg
micro syndrome. These ﬁndings suggest that RAB3GAP dysregulation may result in a spectrum of phenotypes that
range from Warburg micro syndrome to Martsolf syndrome.
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Rab proteins (which belong to the Ras family of small
G proteins) are prime regulators of vesicular membrane
transport in both the exocytic and endocytic pathways.
The active forms of Rab proteins have multiple functions
in cargo selection and as scaffolds for the sequential as-
sembly of effectors required for vesicle budding, cyto-
skeletal transport, and target membrane fusion (Takai
et al. 2001; Zerial and McBride 2001). The four mem-
bers of the Rab3 subfamily (Rab3A, Rab3B, Rab3C, and
Rab3D) have been implicated in regulated exocytosis
of neurotransmitters and hormones (Takai et al. 1996;
Schluter et al. 2002; Li and Chin 2003; Sudhof 2004).
The activity of Rab3 proteins is tightly regulated by
RabGDI (GDP dissociation inhibitor), Rab3GEP, and
RAB3GAP. The latter two determine the balance of ac-
tive (GTP) to inactive (GDP) forms, and RAB3GAP spe-
ciﬁcally converts active Rab3-GTP to the inactive -GDP
form (Fukui et al. 1997; Wada et al. 1997; Nagano et
al. 1998). Rab3A is the most abundantly expressed Rab
protein in the brain and is present in virtually all syn-
apses. Through binding to its effector Rim, Rab3A has
a critical role in the release of neurotransmitter vesi-
cles (Li and Chin 2003; Sudhof 2004). Rab3A, Rab3B,
and Rab3C are also expressed in endocrine tissues, and
Rab3B is expressed at high levels in the anterior pitui-
tary, where it has been implicated in gonadotrophin re-
lease (Tasaka et al. 1998; Schluter et al. 2002). Recently,
we found germline-inactivating mutations in the cata-
lytic subunit of Rab3GAP (RAB3GAP1 [Ensembl acces-
sion number ENSG00000115839; GenBank accession
number D31886]) in 12 of 18 kindreds with Warburg
micro syndrome (MIM 600118) (Aligianis et al. 2005).
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This severe autosomal recessive disorder is character-
ized by ocular defects (microphthalmos, microcornea,
congenital cataracts, and optic atrophy) and neurode-
velopmental ones (microcephaly, cortical gyral abnor-
malities such as pachygyria and polymicrogyria, hypo-
plasia of the corpus callosum, severe mental retarda-
tion, and spastic cerebral palsy) and hypothalamic hypo-
genitalism (Warburg et al. 1993; Rodriguez et al. 1999;
Megarbane et al. 1999; Nassogne et al. 2000; Ains-
worth et al. 2001; Derbent et al. 2004; Graham et al.
2004). Linkage to RAB3GAP1 was excluded in some
families without mutations, conﬁrming locus heteroge-
neity. RAB3GAP is a heterodimeric complex consisting
of a 130-kDa catalytic subunit, encoded by RAB3GAP1
on chromosome 2q21.3, and a 150-kDa noncatalytic
subunit (Fukui et al. 1997; Nagano et al. 1998), the
gene for which—RAB3GAP2 (Ensembl accession num-
ber ENSG00000118873; GenBank accession number
AF004828)—is located on chromosome 1q41. Previ-
ously, we did not detect mutations in RAB3GAP2 in
six families with Warburg micro syndrome without
RAB3GAP1 mutations (Aligianis et al. 2005). However,
to further investigate the potential role of RAB3GAP2,
we (1) analyzed neurodevelopmental expression of
RAB3GAP1 and RAB3GAP2 in a model organism and
(2) undertook further RAB3GAP2 mutation analysis in
Warburg micro syndrome and in the related Martsolf
syndrome (MIM 212720), which shares clinical features
but is a milder disorder.
Expression of RAB3GAP1 and RAB3GAP2 ortho-
logues in zebraﬁsh.—To further investigate the potential
neurodevelopmental role of RAB3GAP2, we compared
the expression patterns of RAB3GAP1 andRAB3GAP2
orthologues in developing and adult zebraﬁsh. Two ESTs
showing similarities to RAB3GAP1 and RAB3GAP2
were identiﬁed through BLAST searches (zebraﬁsh
rab3gap1 [GenBank accession number AI629291] and
rab3gap2 [GenBank accession number CF348222]), and
riboprobes were prepared for in situ hybridization studies.
The zebraﬁsh plasmids were linearized with SalI and
were transcribed with SP6-RNA polymerase, and ribo-
probes were puriﬁed using quick spin columns (Roche)
and were stored in 50% formamide at 70C. In situ
hybridization studies on cryostat sections were performed
as described elsewhere (Costagli et al. 2002). Sections
were then mounted in glycerol. Images were captured
with a Polaroid digital camera connected to a Nikon
Optiphot-2 microscope, by use of #4, #10, and #20
Plan-apo lenses. Digital images were stored as 1,600
pixels at a resolution of 300 dpi and were man-#1,200
ually arranged, to form composite pictures, with Adobe
Photoshop 5.5. Danio rerio aged 2 and 4 wk from the
University College London ﬁsh facility were used in all
experiments. Fish were raised at 28C with a cycle of
14 h light and 10 h darkness. Animals were handled in
accordance with U.K. and European Union regulations
for laboratory animals. Animals were terminally anes-
thetized with 0.3% tricaine methane sulphonate (MS222
[Sigma]) and were ﬁxed overnight in 4% paraformal-
dehyde in 0.1 M phosphate buffer (PB), pH 7.4. They
were then rinsed in PB and were equilibrated in 10%
and 20% sucrose in PB at 4C for 48 h. Tissue was em-
bedded in OCT compound (Agar), was frozen on dry
ice, and was cut serially at 20 mm in coronal and sagittal
planes. Sections were collected on Superfrost slides (BDH)
and were stored at 70C in sealed boxes until ready
to use.
We found that, whereas rab3gap1 was ubiquitously
expressed during development, expression of rab3gap2
started during larval stages (3–4 d postfertilization), and
transcripts could be clearly detected only in the CNS
(data not shown). The analysis of its expression pattern
and the comparison with rab3gap1 expression was con-
ducted in 3–4-wk-old zebraﬁsh (ﬁgs. 1 and 2). Both sub-
units were expressed in the CNS in areas with high neu-
ronal density, and were excluded from the regions en-
riched with ﬁber tracts and neuropil. In the forebrain of
3–4-wk-old zebraﬁsh, the transcripts of both rab3gap
subunits were largely coexpressed in the dorsal (predom-
inantly in the region marked as “Dl” in ﬁg. 1A and 1B)
and ventral (“Vv” in ﬁg. 1A and 1B) telencephalon, in
the posterior region of the dorsal telencephalon (“Dp”
in ﬁg. 1C and 1D), and in the preoptic area (POA) (ﬁg.
1C and 1D). In addition, rab3gap1 was strongly ex-
pressed throughout the hypothalamic region (ﬁg. 1E),
whereas rab3gap2 expression in the hypothalamus was
restricted to the ventral zone (“Hv” in ﬁg. 1F) and the
pituitary (“Pit” in ﬁg. 1F). In the eye, rab3gap1 (ﬁg. 2A)
was strongly expressed throughout the internal nuclear
layer (INL) and was weakly expressed in the photore-
ceptors, whereas the expression of rab3gap2 (ﬁg. 2B)
was conﬁned to the remnants of the ciliary margin (CM),
the proliferative zone of the retina.
Identiﬁcation of a RAB3GAP2 neurodevelopmental
phenotype.—To investigate the role of RAB3GAP2 in
human neurodevelopmental disease, we investigated fam-
ilies with clinical features overlapping those seen inWar-
burg micro syndrome, and we identiﬁed a homozygous
germline RAB3GAP2 mutation in all three children of
a family with a Martsolf syndrome–like phenotype.
Clinical report.—The proband (subject IV-1; see ﬁg.
3) was the ﬁrst child of consanguineous Pakistani par-
ents. He was born at 38 wk by cesarean section, with
a birth weight of 1.87 kg, and was noted to have con-
genital cataracts, microphthalmia, micropenis, and cryp-
torchidism at birth. Bilateral cataract extractionwas per-
formed at age 6 wk. At age 5 mo, he was hypotonic,
and his motor development was delayed. He gained head
control at age ∼1 year and sat at age 2 years, at which
time a brain CT scan was reported as normal. He toe
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Figure 1 Brain expression patterns of rab3gap1 and rab3gap2 in zebraﬁsh. In the forebrain of 3–4-wk-old zebraﬁsh, the transcripts of
both rab3gap subunits are largely coexpressed in the dorsal (predominantly in Dl [A and B]) and ventral (Vv [A and B]) telencephalon, in the
posterior region of the dorsal telencephalon (Dp [C and D]), and in the POA (C and D). In addition, rab3gap1 is strongly expressed throughout
the hypothalamic region (E), whereas rab3gap2 expression in the hypothalamus is restricted to the ventral zone (Hv [F]) and the pituitary (Pit
[F]).
walked from age ∼3.5 years, when spastic diplegia was
noted. His ﬁrst words were at age ∼3 years. At age 11
years, he had mild learning difﬁculties, was microcephalic
(occipitofrontal head circumference [OFC] 49 cm at age
8 years; !3rd percentile) and walked with a walker. He
was bilingual and attended special school. Eye exami-
nation showed small pupils, aphakia, hypermetropia, and
controlled secondary glaucoma. Visual acuity was poor
(2/650 right eye [RVA] and 3/60 left eye [LVA]). There
were no distinctive facial dysmorphisms.
Subject IV-3, the proband’s sister, was born by nor-
mal delivery at 39 wk after an uncomplicated pregnancy.
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Figure 2 Eye expression patterns of rab3gap1 and rab3gap2 in
zebraﬁsh. In the eye, rab3gap1 (A) is strongly expressed throughout
the INL and in the CM and is only weakly expressed in the photo-
receptors (arrows; outer nuclear layer [ONL]), whereas the expression
of rab3gap2 (B) is conﬁned to the remnants of the CM, the proliferative
zone of the retina.
Figure 3 Pedigree of family and ﬁne mapping for markers ﬂank-
ing the RAB3GAP2 gene (which is located between 216712122 and
216834147 bp) on chromosome 1. The parents are in generation III,
and the affected siblings are in generation IV: IV-1, IV-2, and IV-3.
Her birth weight was 3.060 kg, and her OFC was 34
cm (!10th percentile); she had dense bilateral cataracts
and microphthalmia. After cataract surgery at age 4 mo,
she developed secondary glaucoma, which required a
vitrectomy and peripheral iridectomy. Prior to the glau-
coma, her fundal examination was normal. Postsurgery
visual acuity was reduced (RVA 6/38; LVA 6/120). Hy-
potonia was noted in infancy, and she later developed
spastic diplegia. She had global developmental delay and
sat at age 14mo, stoodwith support at age 17mo,walked
with support at age 3 years, and developed speech at
age 2 years. At age 5 years, she had moderate learning
difﬁculties and required special schooling, but she was
bilingual in English and Punjabi. Growth was normal
(height and weight at the 50th percentile), but she had
borderline microcephaly, with an OFC just 13rd per-
centile. She had a low anterior hairline and was hirsute,
but she did not have any distinctive facial dysmorphisms.
Subject IV-2 was born, at term, with congenitally cor-
rected transposition of the great vessels. His birth weight
was 2.4 kg (50th percentile), and OFCwas 33 cm (!10th
percentile). He hadmicropenis and bilateral cryptorchid-
ism, congenital cataracts, and microphthalmia. Left cat-
aract removal was performed at age 2 mo. Immediately
postoperatively, he suffered a cardiac arrest of unknown
etiology, and, following resuscitation and artiﬁcial ven-
tilation, he was found to have severe hypoxic ischemic
encephalopathy with convulsions. His ischemic enceph-
alopathy has been associated with profound global de-
velopmental delay and spastic quadriplegia. CT andmag-
netic resonance imaging (MRI) scans showed cerebral
atrophy in a pattern consistent with hypoxic damage,
and electroencephalogram showed poor background ac-
tivity, with minimal variability and very little central
activity. He was facially hirsute but did not have any
dysmorphic facial features.
Molecular genetic analysis.—A 10-cM genomewide
linkage scan was performed on DNA from all three af-
fected individuals in this family, by use of the Research
Genetics version 10 mapping panel, as described else-
where (Aligianis et al. 2002, 2005). All exons and intron-
exon boundaries were ampliﬁed by PCR and then were
sequenced, by direct sequencing, using the ABI3730 cap-
illary sequencer. The sequencing primers for RAB3GAP1
and PCR conditions are included in table 1. Linkage to
RAB3GAP1 was excluded, but all three affected indi-
viduals were homozygous for a 16-cM region between
markers GATA124F08 and D1S549 that contained the
RAB3GAP2 locus (ﬁg. 3). Additionalmicrosatellitemark-
ers ﬂanking the noncatalytic subunit of RAB3GAP2
(D1S2880, D1S2641, and D1S2689) were typed and
conﬁrmed homozygous-by-descent. We then proceeded
to sequence the 36 exons and intron-exon boundaries
of RAB3GAP2 and detected a homozygous 3154GrT
(Gly1051Cys) missense substitution in all three affected
individuals (ﬁg. 4A). Both parents were heterozygous for
this substitution, and it was not found in the 270 eth-
nically matched control chromosomes. Since the substi-
tution is adjacent to the exon 28 splice-donor site, RNA
was obtained from lymphocytes from two of the affected
children and their parents. Lymphocyte RNA revealed
that this mutation resulted in two transcripts (ﬁg. 4B).
Sequencing of the cDNA synthesized from these tran-
scripts showed that the splice-site mutation resulted in
exon 28 skipping and a frameshift (ﬁg. 4C). Sequencing
analysis of DNA from another family withMartsolf syn-
drome, reported elsewhere (Hennekam et al. 1988), did
not detect a mutation in RAB3GAP2 or RAB3GAP1,
and linkage analysis excluded linkage to both genes.
Also, we did not detect a RAB3GAP2 mutation in an
additional two families with Warburg micro syndrome
without RAB3GAP1 mutations.
Germline mutations in RAB3GAP2 have not been
reported elsewhere. Although it has been shown that
the noncatalytic subunit does not inﬂuence RAB3GAP
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Table 1
PCR Primers and Conditions Used for RAB3GAP2
Sequencing
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Figure 4 The 3154GrT mutation in RAB3GAP2. The legend
is available in its entirety in the online edition of The American Journal
of Human Genetics.
catalytic activity, our ﬁndings suggest a critical role for
Rab3GAP2 in human development. The expression of
rab3gap2 during zebraﬁsh embryogenesis is consistent
with the neurodevelopmental phenotype of RAB3GAP2
mutation in humans. Elsewhere, we found that, in mouse
embryos, Rab3gap1 showed a low level of general ex-
pression throughout the embryo from E10 to E12. In
addition to this continued generalized expression, there
was also prominent expression in a number of organ
systems, including the CNS and peripheral nervous sys-
tem, at E14.5 (Aligianis et al. 2005). Consistent with
this, we found that rab3gap1 is ubiquitously expressed
during zebraﬁsh development. However, an unexpected
and intriguing ﬁnding was the observed differences be-
tween rab3gap1 and rab3gap2 expression patterns in
developing zebraﬁsh. Thus, rab3gap2 expression was re-
stricted to the CNS, which suggests that this dictates the
localization of Rab3gap activity during embryogenesis
and hence explains the developmental phenotype of War-
burg micro syndrome despite ubiquitous rab3gap1 ex-
pression. We note that hypothalamic hypogonadism is
a feature of Warburg micro syndrome and that, in ze-
braﬁsh, rab3gap1 is strongly expressed throughout the
hypothalamic region. In contrast, rab3gap2 expression
in the hypothalamus is restricted to the ventral zone
and the pituitary. In the eye, rab3gap1 was strongly ex-
pressed throughout the INL and in the photoreceptors,
whereas rab3gap2 expression was conﬁned to the rem-
nants of the CM. We note that, in ﬁsh, the retina con-
tinues to grow with the eye throughout the life of the
animal, and new retinal cells are added at the CM from
neural glial stem cells. Further comparative studies of
RAB3GAP1 and RAB3GAP2 expression in mice and
humans may provide further insights into the relation-
ship between these expression patterns and the Warburg
micro syndrome and Martsolf syndrome phenotypes.
The precise mechanisms whereby RAB3GAP1 and
RAB3GAP2 mutations cause human disease is unclear.
In Warburg micro syndrome,RAB3GAP1mutations are
associated with microgenitalia that may result from hy-
pothalamic hypogonadotropinism and disordered neuro-
transmitter vesicle release. Ocular and neurodevelopmen-
tal defects and functional deﬁcits might result either from
abnormal neurotransmitter vesicular transport and ex-
ocytosis and/or from abnormal neurotrophic vesicle
release during human development. In total, we ana-
lyzed 26 families with Warburg micro syndrome and
two families with Martsolf syndrome for mutations in
RAB3GAP1 and RAB3GAP2. In 18 of 26 families with
Warburg micro syndrome, we identiﬁed RAB3GAP1
mutations but no RAB3GAP2 mutations, which con-
ﬁrms that Warburg micro syndrome is a heterogeneous
condition. However, a homozygous RAB3GAP2 mis-
sense mutation that resulted in aberrant splicing was
identiﬁed in one family with Martsolf syndrome (three
siblings), but no RAB3GAP1 or RAB3GAP2 mutations
were found in our other Martsolf kindred (Aligianis et
al. 2005). The RAB3GAP2-mutation phenotype was
milder than that seen with RAB3GAP1 mutations in
Warburg micro syndrome. Martsolf syndrome was re-
ported in 1978 (Martsolf et al. 1978) in two brothers
of Polish-Jewish origin with severe mental retardation,
cataracts, short stature, primary hypogonadism, and mi-
nor digital and cephalic abnormalities. Since then, there
have been several case reports of children with congen-
ital cataracts, mental retardation, and hypogonadism
to which the eponym Martsolf syndrome has been at-
tached. These have conﬁrmed autosomal recessive in-
heritance and further delineated the condition’s clinical
features (table 2) (Sanchez et al. 1985; Hennekam et al.
1988; Strisciuglio et al. 1988; Harbord et al. 1989). The
minor features that have been described as being part
of the condition can include brachycephaly, lax ﬁnger
joints, talipes valgus, a pouting mouth, maxillary retru-
sion, and slight hirsutism. Although facial dysmorphisms
have been described, these are subtle, and Harbord et
al. (1989) described a family with Martsolf syndrome
that did not have any distinctive dysmorphic features
(members were microcephalic, with small jaws and slight
hirsutism). Martsolf syndrome has many features in
common with Warburg micro syndrome, but the ocu-
lar and neurodevelopmental defects are less severe in
Martsolf syndrome. At present, it is unclear whether
the milder phenotype observed in our family with an
RAB3GAP2 mutation (compared with that observed
for RAB3GAP1 mutations causing Warburg micro syn-
drome) is because either (1) the p130 subunit is more
critical than the p150 subunit for Rab3GAP function or
(2) the “leaky” nature of the splicing defect caused by
the RAB3GAP2 mutation allowed some normal protein
to be produced and so ameliorated the clinical phenotype.
Our ﬁndings have (1) demonstrated ocular and CNS
expression speciﬁcity for RABGAP2, (2) demonstrated
genetic heterogeneity in Martsolf syndrome phenotypes,
(3) linked Warburg micro syndrome and Martsolf syn-
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Table 2
A Comparison of the Clinical Features of Micro
Syndrome, the Reported Martsolf Cases,
and the Family Described in the Present Report
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
drome phenotypes such that novel genes for one disorder
may be considered as candidate genes for the other, and
(4) expanded the phenotypic spectrum of Rab3GAP dys-
function. Further mutation analysis of RAB3GAP1 and
RAB3GAP2 in neurodevelopmental disorders associated
with Warburg micro/Martsolf syndrome–like ocular and
gonadal defects will provide insights into the phenotypic
consequences of Rab3GAP dysfunction in human disease.
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